Stay updated on Lenvatinib+Pembrolizumab in Metastatic Gastroesophageal Cancer Clinical Trial

Sign up to get notified when there's something new on the Lenvatinib+Pembrolizumab in Metastatic Gastroesophageal Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Lenvatinib+Pembrolizumab in Metastatic Gastroesophageal Cancer Clinical Trial page

  1. Check
    7 days ago
    Change Detected
    Summary
    The footer revision label changes from v3.7.1 to v3.7.2, while the page continues to display a 403 Forbidden error.
    Difference
    0.2%
    Check dated 2026-10-18T02:39:56.000Z thumbnail image
  2. Check
    14 days ago
    Change Detected
    Summary
    The footer revision identifier changes from `v3.7.0` to `v3.7.1`; the page continues to display a 403 Forbidden error.
    Difference
    0.2%
    Check dated 2026-10-11T03:16:53.000Z thumbnail image
  3. Check
    21 days ago
    No Change Detected
  4. Check
    35 days ago
    Change Detected
    Summary
    A 403 Forbidden page is now displayed in place of the study record, blocking access to the trial's details and attached documents. This prevents users from viewing core trial information such as the study description, eligibility, and related materials on the page.
    Difference
    15%
    Check dated 2026-09-20T01:29:50.000Z thumbnail image
  5. Check
    56 days ago
    Change Detected
    Summary
    A revision tag 'Revision: v3.6.6' was added and the previous tag 'Revision: v3.6.5' was removed, indicating a software revision update to the page. This change does not alter the displayed content or functionality.
    Difference
    0.0%
    Check dated 2026-08-29T19:47:40.000Z thumbnail image
  6. Check
    78 days ago
    Change Detected
    Summary
    New revision label v3.6.5 appears in the page’s revision history, replacing the previous v3.6.4. This indicates a minor update to the page’s version metadata rather than substantive changes to study details.
    Difference
    0.0%
    Check dated 2026-08-08T10:03:34.000Z thumbnail image
  7. Check
    92 days ago
    Change Detected
    Summary
    Revision metadata on the page was updated from v3.6.3 to v3.6.4. This reflects a minor update to the page's underlying data or tooling rather than a user-facing change.
    Difference
    0.0%
    Check dated 2026-07-25T06:23:07.000Z thumbnail image

Stay in the know with updates to Lenvatinib+Pembrolizumab in Metastatic Gastroesophageal Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Lenvatinib+Pembrolizumab in Metastatic Gastroesophageal Cancer Clinical Trial page.